Abstract:Abstract Background Xanthine dehydrogenase (XDH) is a critical enzyme involved in the oxidative metabolism of purines, pterin and aldehydes and a central component of the innate immune system. However, the prognostic value of XDH in predicting tumor-infiltrating lymphocyte abundance, the immune response, and survival in different cancers, including hepatocellular carcinoma (HCC), is still unclear. Methods XDH expression was analyzed in multiple databases, including Oncomine, the Tumor Immune Estimation Resource (TIMER), the Kaplan–Meier plotter database, the Gene Expression Profiling Interactive Analysis (GEPIA) database, and The Cancer Genome Atlas (TCGA). XDH-associated transcriptional profiles were detected with an mRNA array, and the levels of infiltrating immune cells were validated by immunohistochemistry (IHC) of HCC tissues. A predictive signature containing multiple XDH-associated immune genes was established using the Cox regression model. Results Decreased XDH mRNA expression was detected in human cancers originating from the liver, bladder, breast, colon, bile duct, kidney, and hematolymphoid system. The prognostic potential of XDH mRNA expression was also significant in certain other cancers, including HCC, breast cancer, kidney or bladder carcinoma, gastric cancer, mesothelioma, lung cancer, and ovarian cancer. In HCC, a low XDH mRNA level predicted poorer overall survival, disease-specific survival, disease-free survival, and progression-free survival. The prognostic value of XDH was independent of the clinical features of HCC patients. Indeed, XDH expression in HCC activated several immune-related pathways, including the T cell receptor, PI3K-AKT, and MAPK signaling pathways, which induced a cytotoxic immune response. Importantly, the microenvironment of XDH high HCC tumors contained abundant infiltrating CD8 + T cells but not exhausted T cells. A risk prediction signature based on multiple XDH-associated immune genes was revealed as an independent predictor in the TCGA liver cancer cohort. Conclusion These findings suggest that XDH is a valuable prognostic biomarker in HCC and other cancers and indicate that it may function in tumor immunology. Loss of XDH expression may be an immune evasion mechanism for HCC.

XPD Functions As a Tumor Suppressor and Dysregulates Autophagy in Cultured HepG2 Cells

Xeroderma Pigmentosum group D suppresses proliferation and promotes apoptosis of HepG2 cells by downregulating ERG expression via the PPAR pathway

Nucleotide Excision Repair Gene Subunit Xpd is Highly Expressed in Cervical Squamous Cell Carcinoma

Targeting XPO6 Inhibits Prostate Cancer Progression and Enhances the Suppressive Efficacy of Docetaxel

The Role of XPD in Cell Apoptosis and Viability and Its Relationship with P53 and Cdk2 in Hepatoma Cells

Silencing of Xeroderma Pigmentosum Group D Gene Promotes Hepatoma Cell Growth by Reducing P53 Expression

A Meta-Analysis of Xeroderma Pigmentosum Gene D Ls751gln Polymorphism and Susceptibility to Hepatocellular Carcinoma

Effect of Polymorphisms in Xpd on Clinical Outcomes of Platinum-Based Chemotherapy for Chinese Non-Small Cell Lung Cancer Patients

Glucose-6-phosphate Dehydrogenase (G6PD): the Role in Tumor Progression and Immunotherapy

The Promoting Effects of Xeroderma Pigmentosum D Gene on Proliferation of Human Umbilical Vein Endothelia Cells

Protocadherin 17 Acts As a Tumour Suppressor Inducing Tumour Cell Apoptosis and Autophagy, and is Frequently Methylated in Gastric and Colorectal Cancers

A Systematic Pan-Cancer Analysis of PXDN As a Potential Target for Clinical Diagnosis and Treatment

NOP2-mediated m5C methylation of XPD is associated with hepatocellular carcinoma progression

Cloning of the XPD gene and its function in malignant melanoma cells

XPD localizes in mitochondria and protects the mitochondrial genome from oxidative DNA damage

Role of Xeroderma pigmentosum D (XPD) protein in genome maintenance in human cells under oxidative stress

Effects of xeroderma pigmentosum D on proliferation induced by interleukin-6 in vascular smooth muscle cells

Effect of Xeroderma Pigmentosum Group D Gene on Proliferation of Hu-Man Umbilical Arterial Smooth Muscle Cells Induced by Ox-LDL

Overexpression of Xeroderma Pigmentosum Group C Decreases the Chemotherapeutic Sensitivity of Colorectal Carcinoma Cells to Cisplatin

Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma

Identification of Clinical Value and Biological Effects of XIRP2 Mutation in Hepatocellular Carcinoma